Triple
T4618909
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Zodiac |
E100931
|
entity |
| Predicate | hasPart |
P35
|
FINISHED |
| Object | Cancer |
E137795
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Cancer | Statement: [Zodiac, hasPart, Cancer]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Cancer Context triple: [Zodiac, hasPart, Cancer]
-
A.
Cancer
chosen
Cancer is the fourth astrological sign of the zodiac, symbolized by the Crab and traditionally associated with emotional sensitivity, intuition, and nurturing qualities.
-
B.
Cancer Research
Cancer Research is a leading peer-reviewed scientific journal that publishes significant findings in oncology, including basic, translational, and clinical cancer research.
-
C.
Cancer Programs
Cancer Programs is a set of initiatives and standards by the American College of Surgeons focused on improving the quality and outcomes of cancer care across accredited institutions.
-
D.
Cancer Discovery
Cancer Discovery is a leading peer-reviewed scientific journal that publishes cutting-edge research and clinical studies in oncology.
-
E.
Division of Cancer Treatment and Diagnosis
The Division of Cancer Treatment and Diagnosis is a branch of the National Cancer Institute that supports the development, evaluation, and clinical testing of new cancer therapies and diagnostic tools.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69bd43cf363c819087fd5ab441b4a3f4 |
completed | March 20, 2026, 12:55 p.m. |
| NER | Named-entity recognition | batch_69bd59e247448190ad92f194cb1127c5 |
completed | March 20, 2026, 2:29 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69bdfa916f4c8190a53bb37ff46ed0b5 |
completed | March 21, 2026, 1:55 a.m. |
Created at: March 20, 2026, 1:12 p.m.